270 related articles for article (PubMed ID: 28196644)
21. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in cutaneous HPV infection.
Shimizu A; Yamaguchi R; Kuriyama Y
J Dermatol; 2023 Mar; 50(3):290-298. PubMed ID: 36601717
[TBL] [Abstract][Full Text] [Related]
23. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
[TBL] [Abstract][Full Text] [Related]
24. Lifelong widespread warts associated with human papillomavirus type 70/85: a new diagnostic entity?
Giuliodori K; Campanati A; Liberati G; Ganzetti G; Giangiacomi M; Marinelli K; Cataldi I; Marconi B; Offidani A
Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):11-3. PubMed ID: 27014773
[TBL] [Abstract][Full Text] [Related]
25. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
26. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
Esenboga S; Cagdas D; Alkanat NE; Güler Tezel G; Ersoy Evans S; Boztug K; Tezcan I
J Cosmet Dermatol; 2022 May; 21(5):2263-2267. PubMed ID: 34416085
[TBL] [Abstract][Full Text] [Related]
27. Epidermodysplasia verruciformis and generalized verrucosis: the same disease?
Yanagi T; Shibaki A; Tsuji-Abe Y; Yokota K; Shimizu H
Clin Exp Dermatol; 2006 May; 31(3):390-3. PubMed ID: 16681585
[TBL] [Abstract][Full Text] [Related]
28. Epidermodysplasia-verruciformis-like eruption associated with gamma-papillomavirus infection in a patient with adult T-cell leukemia.
Kawai K; Egawa N; Kiyono T; Kanekura T
Dermatology; 2009; 219(3):274-8. PubMed ID: 19696474
[TBL] [Abstract][Full Text] [Related]
29. Epidermodysplasia Verruciformis After Hematopoietic Stem Cell Transplantation in a Patient With Severe Combined Immunodeficiency Syndrome.
Bostan E; Akdogan N; Gokoz O
Am J Dermatopathol; 2021 May; 43(5):e65-e67. PubMed ID: 33577180
[TBL] [Abstract][Full Text] [Related]
30. Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.
de Jong SJ; Imahorn E; Itin P; Uitto J; Orth G; Jouanguy E; Casanova JL; Burger B
Front Microbiol; 2018; 9():1222. PubMed ID: 29946305
[TBL] [Abstract][Full Text] [Related]
31. Epidermodysplasia verruciformis and human papilloma virus.
Gewirtzman A; Bartlett B; Tyring S
Curr Opin Infect Dis; 2008 Apr; 21(2):141-6. PubMed ID: 18317036
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus and squamous cell cancer of the skin--epidermodysplasia verruciformis-associated human papillomavirus revisited.
Arnold AW; Hofbauer GF
Curr Probl Dermatol; 2012; 43():49-56. PubMed ID: 22377919
[TBL] [Abstract][Full Text] [Related]
33. Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms.
Mertz KD; Schmid M; Burger B; Itin P; Palmedo G; Schärer L; Kutzner H; Fernández Figueras MT; Cribier B; Pfaltz M; Kempf W
Dermatology; 2011 Feb; 222(1):87-92. PubMed ID: 21099200
[TBL] [Abstract][Full Text] [Related]
34. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.
Crequer A; Picard C; Patin E; D'Amico A; Abhyankar A; Munzer M; Debré M; Zhang SY; de Saint-Basile G; Fischer A; Abel L; Orth G; Casanova JL; Jouanguy E
PLoS One; 2012; 7(8):e44010. PubMed ID: 22952854
[TBL] [Abstract][Full Text] [Related]
35. Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient.
Gober MD; Rady PL; He Q; Tucker SB; Tyring SK; Gaspari AA
J Invest Dermatol; 2007 Apr; 127(4):817-20. PubMed ID: 17139267
[TBL] [Abstract][Full Text] [Related]
36. Acquired Epidermodysplasia Verruciformis in the Setting of Renal Transplant.
Henning A; Weaver J; Reedy M
Am J Dermatopathol; 2021 Jan; 43(1):71-74. PubMed ID: 32568838
[TBL] [Abstract][Full Text] [Related]
37. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.
de Jong SJ; Créquer A; Matos I; Hum D; Gunasekharan V; Lorenzo L; Jabot-Hanin F; Imahorn E; Arias AA; Vahidnezhad H; Youssefian L; Markle JG; Patin E; D'Amico A; Wang CQF; Full F; Ensser A; Leisner TM; Parise LV; Bouaziz M; Maya NP; Cadena XR; Saka B; Saeidian AH; Aghazadeh N; Zeinali S; Itin P; Krueger JG; Laimins L; Abel L; Fuchs E; Uitto J; Franco JL; Burger B; Orth G; Jouanguy E; Casanova JL
J Exp Med; 2018 Sep; 215(9):2289-2310. PubMed ID: 30068544
[TBL] [Abstract][Full Text] [Related]
38. EVER2 deficiency is associated with mild T-cell abnormalities.
Crequer A; Picard C; Pedergnana V; Lim A; Zhang SY; Abel L; Majewski S; Casanova JL; Jablonska S; Orth G; Jouanguy E
J Clin Immunol; 2013 Jan; 33(1):14-21. PubMed ID: 22903682
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of p16 protein expression in squamous cell carcinomas from patients with epidermodysplasia verruciformis and patients without the disease.
Mattos MSG; Oliveira WR; Sotto MN
Arch Dermatol Res; 2017 Aug; 309(6):479-483. PubMed ID: 28439661
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis.
Zuo YG; Ma D; Zhang Y; Qiao J; Wang B
J Dermatol Sci; 2006 Dec; 44(3):153-9. PubMed ID: 17008061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
